Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades

被引:49
作者
Lakka, SS
Jasti, SL
Kyritsis, AP
Yung, WKA
Ali-Osman, F
Nicolson, GL
Rao, JS
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA
[3] Inst Mol Med, Huntington Beach, CA USA
关键词
MMP-9; type IV collagenase; glioblastoma; JNK; ERK;
D O I
10.1023/A:1006724826083
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our previous studies have shown that MMP-9 levels are significantly elevated during the progression of human gliomas. In the current study, we examined the role of JNK- and ERK-dependent signaling modules in the regulation of MMP-9 production and the invasive behavior of the human glioblastoma cell line SNB19, in which JNK/ERK1 is constitutively activated. SNB19 cells that were transfected with dominant-negative JNK, MEKK, and ERK1 expression vectors showed reduced MMP-9 promoter activity. In addition, conditioned medium collected from SNB19 cells transfected with these expression vectors showed diminished MMP-9 activity in the presence of phorbol myristate acetate, as determined by gelatin zymography. The cotransfection of SNB19 cells with kinase-deficient c-raf also diminished MMP-9 promoter activity. Further, in the presence of a specific inhibitor of MEKK (PD098059), the Matrigel invasion assay showed the invasiveness of dominant-negative SNB19 cells transfected with dominant-negative JNK1 or ERK1 to be remarkably reduced. In conclusion, our studies showed for the first time that MMP-9 production and the invasive behavior of SNB19 cells are regulated by JNK- and ERK-dependent signaling modules and that interfering with either of the pathways reduces invasiveness.
引用
收藏
页码:245 / 252
页数:8
相关论文
共 48 条
[21]   CYTOKINE-MEDIATED REGULATION OF RAT OVARIAN-FUNCTION - INTERLEUKIN-1 STIMULATES THE ACCUMULATION OF A 92-KILODALTON GELATINASE [J].
HURWITZ, A ;
DUSHNIK, M ;
SOLOMON, H ;
BENCHETRIT, A ;
FINCIYEHESKEL, Z ;
MILWIDSKY, A ;
MAYER, M ;
ADASHI, EY ;
YAGEL, S .
ENDOCRINOLOGY, 1993, 132 (06) :2709-2714
[22]   GROWTH-FACTORS AND GANGLIOSIDES STIMULATE LAMININ PRODUCTION BY HUMAN GLIOMA-CELLS IN-VITRO [J].
KOOCHEKPOUR, S ;
MERZAK, A ;
PILKINGTON, GJ .
NEUROSCIENCE LETTERS, 1995, 186 (01) :53-56
[23]   Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors [J].
Lampert, K ;
Machein, U ;
Machein, MR ;
Conca, W ;
Peter, HH ;
Volk, B .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (02) :429-437
[24]   DIFFERENTIAL ACTIVATION OF ERK AND JNK MITOGEN-ACTIVATED PROTEIN-KINASES BY RAF-1 AND MEKK [J].
MINDEN, A ;
LIN, A ;
MCMAHON, M ;
LANGECARTER, C ;
DERIJARD, B ;
DAVIS, RJ ;
JOHNSON, GL ;
KARIN, M .
SCIENCE, 1994, 266 (5191) :1719-1723
[25]  
Miyagi N, 1998, INT J ONCOL, V12, P1085
[26]  
MOHANAM S, 1993, CANCER RES, V53, P4143
[27]  
NAKAJIMA M, 1993, CANCER RES, V53, P5802
[28]   Expression and localization of 92 kDa type IV collagenase gelatinase B (MMP-9) in human gliomas [J].
Rao, JS ;
Yamamoto, M ;
Mohaman, S ;
Gokaslan, ZL ;
Fuller, GN ;
StetlerStevenson, WG ;
Rao, VH ;
Liotta, LA ;
Nicolson, GL ;
Sawaya, RE .
CLINICAL & EXPERIMENTAL METASTASIS, 1996, 14 (01) :12-18
[29]  
RAO JS, 1993, CANCER RES, V53, P2208
[30]  
REITH A, 1994, ANTICANCER RES, V14, P1071